MarketCap
Integra LifeSciences Holdings Corporation IART
$ 15.88
2.25%
Facebook
X
Telegram
Integra LifeSciences Holdings Corporation Interest Expense | IART
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Integra LifeSciences Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.35 M | 3.94 M | 51.4 M | 49.6 M | 50.4 M | 71.6 M | 54 M | 64.7 M | 35 M | 25.8 M | 23.5 M | 22 M | 19.7 M | 22.2 M | 27.6 M | 18.4 M | 23.2 M | 30.1 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 71.6 M | -2.35 M | 32.8 M |
Quarterly Interest Expense Integra LifeSciences Holdings Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.19 M | 4.48 M | -842 K | -1.95 M | -144 K | 2.11 M | 1.44 M | -610 K | 471 K | -155 K | 12.1 M | - | 12.8 M | 12.2 M | 11.7 M | - | 12.2 M | 13.1 M | 12.9 M | - | 20.8 M | 15.7 M | 17.8 M | - | 14 M | 13.4 M | 13.1 M | - | 14.5 M | 17.5 M | 18.8 M | - | 6.76 M | 6.18 M | 5.13 M | - | 6.3 M | 6.59 M | 6.37 M | - | 6.46 M | 5.48 M | 5.47 M | - | 5.91 M | 5.38 M | 5.14 M | - | 5.32 M | 4.96 M | 4.8 M | - | 5.55 M | 7.1 M | 7.93 M | - | 7.59 M | 6.72 M | 5.47 M | 4.39 M | 4.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.8 M | -1.95 M | 7.69 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M |  USA |
 |
Bruker Corporation
BRKR
|
-46.2 M | $ 64.0 | 7.26 % | $ 9.72 B | USA |
 |
Boston Scientific Corporation
BSX
|
349 M | $ 44.68 | 0.06 % | $ 66.1 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
-3.76 M | $ 8.7 | 0.06 % | $ 634 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
-146 K | $ 14.61 | 13.03 % | $ 414 M | USA |
 |
CONMED Corporation
CNMD
|
31.1 M | $ 45.18 | 3.31 % | $ 1.4 B | USA |
 |
Eargo
EAR
|
549 K | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
-70 K | $ 16.08 | 0.75 % | $ 576 M | USA |
 |
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | USA |
 |
Electromed
ELMD
|
455 K | $ 27.86 | 1.05 % | $ 230 M | USA |
 |
Establishment Labs Holdings
ESTA
|
5.82 M | $ 65.58 | 3.69 % | $ 1.94 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 85.73 | 0.32 % | $ 50.1 B | USA |
 |
Nemaura Medical
NMRD
|
-6.41 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
AdaptHealth Corp.
AHCO
|
-274 K | $ 5.57 | 0.43 % | $ 753 M | USA |
 |
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.9 | 0.69 % | $ 63.9 M | USA |
 |
Inogen
INGN
|
2.44 M | $ 5.23 | 2.75 % | $ 139 M | USA |
 |
InMode Ltd.
INMD
|
4.71 M | $ 14.19 | 0.21 % | $ 917 M | Israel |
 |
Inspire Medical Systems
INSP
|
-2.66 M | $ 68.81 | 0.59 % | $ 2.02 B | USA |
 |
Neovasc
NVCN
|
133 K | - | - | $ 111 M |  Canada |
 |
IRadimed Corporation
IRMD
|
164 K | $ 85.2 | 0.08 % | $ 1.08 B | USA |
 |
AxoGen
AXGN
|
167 K | $ 43.32 | 0.48 % | $ 1.99 B | USA |
 |
Align Technology
ALGN
|
7.68 M | $ 145.63 | 4.36 % | $ 10.6 B | USA |
|
LENSAR
LNSR
|
636 K | $ 7.08 | 0.28 % | $ 84.7 M | USA |
 |
Sientra
SIEN
|
9.11 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
6.87 M | - | - | $ 1.07 B | USA |
 |
Medtronic PLC
MDT
|
384 M | $ 88.51 | 0.32 % | $ 113 B | USA |
 |
MiMedx Group
MDXG
|
-558 K | $ 4.71 | 0.1 % | $ 696 M | USA |
 |
Surgalign Holdings
SRGA
|
1.01 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
6.9 M | - | - | $ 12.3 B | USA |
 |
Myomo
MYO
|
-668 K | $ 1.67 | 1.83 % | $ 69.9 M | USA |
 |
InspireMD
NSPR
|
200 K | $ 0.7 | 0.37 % | $ 45 M | Israel |
 |
Orthofix Medical
OFIX
|
8.11 M | $ 9.16 | 0.11 % | $ 363 M |  Curacao |
 |
Outset Medical
OM
|
14 M | $ 3.13 | 1.29 % | $ 47.6 K | USA |
 |
Insulet Corporation
PODD
|
14.3 M | $ 135.78 | 0.01 % | $ 9.55 B | USA |
 |
Profound Medical Corp.
PROF
|
146 K | $ 5.6 | 1.66 % | $ 169 M | Canada |
 |
Titan Medical
TMDI
|
1.09 M | - | -26.32 % | $ 19.6 M | Canada |
 |
Quanterix Corporation
QTRX
|
157 K | $ 3.18 | 0.63 % | $ 136 M | USA |
 |
Natus Medical Incorporated
NTUS
|
1.87 M | - | 1.94 % | $ 1.05 B | USA |
 |
AVITA Medical
RCEL
|
5 M | $ 11.58 | 5.75 % | $ 323 M |  Australia |
 |
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
-161 K | $ 2.83 | 1.37 % | $ 116 M | USA |
 |
Sintx Technologies
SINT
|
31 K | $ 1.87 | 5.06 % | $ 5.19 M | USA |
 |
Accuray Incorporated
ARAY
|
5.01 M | $ 0.22 | 0.4 % | $ 27 M | USA |
 |
Smith & Nephew plc
SNN
|
140 M | $ 26.68 | 0.02 % | $ 23.1 B | Britain |
 |
Inari Medical
NARI
|
196 K | - | - | $ 4.23 B | USA |